BioHealth News
Rockville’s GlycoMimetics Announces Positive Initial Safety and Pharmacokinetic Results from Phase 1a Healthy Volunteer Study of GMI-1687
ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced positive…
Read More
NIH: Artificial Intelligence and Your Health – How Computers are Helping Medicine
There’s a lot of talk about artificial intelligence, or AI, these days. AI is everywhere—from virtual assistants to facial recognition software. The technology is…
Read More
TEDCO Invests in PediaMetrix
Maryland biotechnology company promotes improved patient outcomes for infants with body deformities COLUMBIA, Md. (January 3, 2024) – TEDCO, Maryland’s economic engine for technology companies, announced…
Read More
Sonavex Announces Successful Clinical Study of EchoMark & EchoSure and Initiation of the MAFASA Randomized Controlled Trial
FDA IDE approval of Sonavex's randomized trial comes months after meeting the endpoint of its first clinical study BALTIMORE, Jan. 2, 2024 /PRNewswire-PRWeb/ -- Sonavex, Inc., a…
Read More
NSF announces first-ever Accelerating Research Translation awards to empower academic institutions to speed and scale translational research (GMU a winner)
The U.S. National Science Foundation today announced the first-ever Accelerating Research Translation (ART) investment — more than $100 million to 18 teams at academic…
Read More
Advancing Hope: Solaxa’s Quest to Treat Cerebellar Ataxias on the BioTalk Podcast
In this episode of BioTalk with Rich Bendis, we’re joined by three guests from Solaxa: CEO & Founder Christian Walker, Chief Operating Officer Luis…
Read More
The Frederick News-Post: CarrTech seeks FDA approval for product to prevent glass contamination in medication
Sue Carr clearly remembers the moment that pushed her to become a full-time entrepreneur. In 2018, Carr was working at a hospital in Montgomery…
Read More
BHI/NIH EIR Anna Zornosa: “Was 2023 Actually a GOOD Year in Women’s Health?”
The year “gaslighting” of women with hard-to-diagnose maladies was finally given the kabosh? The year we found the hormone causing acute morning sickness? Impressive…
Read More
Barinthus Bio New partnership aims to advance vaccine against MERS coronavirus
CEPI to invest funding of up to $34.8 million to Barinthus Bio in addition to funds previously committed to the University of Oxford to…
Read More
Deka Biosciences Adds Industry Veterans to its Executive Leadership Team and Board of Directors
GERMANTOWN, Md., Dec. 19, 2023 /PRNewswire/ -- Deka Biosciences ("Deka") today announced the appointments of Stanley Frankel, M.D., FACP, as senior clinical advisor, interim chief medical officer…
Read More
University of Maryland School of Medicine Researchers Discover First Ever Link Between Hemoglobin-Like Protein and Normal Cardiac Development
In a landmark study led by the University of Maryland School of Medicine, researchers discovered for the first time that a certain kind of…
Read More
Aurinia Submits IND Application to US Food & Drug Administration for AUR 200
AUR200, a potent recombinant fusion protein, has a clinically validated MOA with a high affinity for targeting both BAFF (B-cell Activating Factor) and APRIL…
Read More
JD SUPRA: Federal Government Releases Proposed Guidance for Exercising “March-In” Rights Under the Bayh-Dole Act: Q & A
On December 8, 2023, the National Institute of Standards and Technology (NIST) published a draft guidance document regarding the government’s exercise of “march-in” rights…
Read More
Smart Incentives: Our top incentive trends
by Ellen D. Harpel | Dec 17, 2023 As Smart Incentives marks its 10th year, we have been revealing the top ten ways that incentives have changed since…
Read More
Navigating the AI Wave: Dr. Juergen Klenk Explores AI’s Reality in the BioHealth Industry on BioTalk
Have you ever wondered about the true impact of Artificial Intelligence (AI) in the BioHealth industry? In this episode of BioTalk with Rich Bendis,…
Read More